- Home
- BXC vs EIKN Comparison
BXC vs EIKN Comparison
Compare BXC & EIKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BXC | EIKN |
|---|---|---|
| Founded | 2004 | 2019 |
| Country | United States | United States |
| Employees | 1700 | N/A |
| Industry | Wholesale Distributors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 706.5M | 631.0M |
| IPO Year | 2004 | 2026 |
Fundamental Metrics
Financial Performance| Metric | BXC | EIKN |
|---|---|---|
| Price | $80.37 | $10.77 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $71.50 | $25.60 |
| AVG Volume (30 Days) | 99.7K | ★ 466.8K |
| Earning Date | 05-05-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.62 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $5.04 | N/A |
| Revenue Next Year | $5.09 | N/A |
| P/E Ratio | $129.15 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $44.78 | $7.90 |
| 52 Week High | $93.80 | $16.50 |
Technical Indicators
Market Signals| Indicator | BXC | EIKN |
|---|---|---|
| Relative Strength Index (RSI) | 54.21 | 50.04 |
| Support Level | $73.99 | $8.43 |
| Resistance Level | $80.57 | $12.16 |
| Average True Range (ATR) | 3.48 | 0.90 |
| MACD | -1.12 | -0.10 |
| Stochastic Oscillator | 50.60 | 24.48 |
Price Performance
Historical ComparisonAbout BXC Bluelinx Holdings Inc.
BlueLinx Holdings Inc is engaged in the wholesale distribution of residential and commercial building products. Its business products are split into two categories: Structural products include items such as lumber, plywood, oriented strand board, rebar, and remesh, and Specialty products include items such as engineered wood, siding, millwork, outdoor living, specialty lumber and panels, and industrial products. The company's operations are carried out throughout the United States.
About EIKN Eikon Therapeutics Inc. Common Stock
Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.